Document is current
Any future updates will be listed below
-
Authors
Haynes, David
Trempe, Eric
Iwan, Allison
Osegueda, Eduardo
Sarkin, Courtney
Cross, Dori
Begnaud, Abbie
Newcomer, Kris
Parsons, Helen M.
Mandic, Pinar Karaca
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Science (UL1TR002494, UL1TR002494, UL1TR002494, UL1TR002494)
National Institutes of Health Award Number (UL1TR002377)
National Heart, Lung, and Blood Institute (T32HL150452, T32HL150452)
Masonic Cancer Center (P30CA077598, P30CA077598, P30CA077598, P30CA077598)
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 4 May 2025
First Online: 5 June 2025
Declarations
:
: This is an observational study and the research was determined to be non-human subjects by the University of Minnesota Institutional Review Board.
: Informed consent was obtained from all individual participants included in the study.
: Dr. Karaca Mandic and Dr. Haynes hold executive positions and equity in XanthosHealth, a University of Minnesota start-up developing a social care referral platform for oncology. This relationship is managed by the Conflict of Interest office at the University of Minnesota. XanthosHealth has filed for a full utility patent with the U.S. Patent and Trademark Office on July 14, 2024. Eduardo is a staff member of XanthosHealth.
